These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10670732)
1. Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection. Lamotte C; Peytavin G; Farinotti R J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):159-70. PubMed ID: 10670732 [TBL] [Abstract][Full Text] [Related]
2. Simple and rapid high-performance liquid chromatographic method for nelfinavir, M8 nelfinavir metabolite, ritonavir and saquinavir assay in plasma. Janoly A; Bleyzac N; Favetta P; Gagneu MC; Bourhis Y; Coudray S; Oger I; Aulagner G J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):155-60. PubMed ID: 12383491 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography. Hugen PW; Verweij-van Wissen CP; Burger DM; Wuis EW; Koopmans PP; Hekster YA J Chromatogr B Biomed Sci Appl; 1999 Apr; 727(1-2):139-49. PubMed ID: 10360433 [TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects. Regazzi M; Maserati R; Villani P; Cusato M; Zucchi P; Briganti E; Roda R; Sacchelli L; Gatti F; Delle Foglie P; Nardini G; Fabris P; Mori F; Castelli P; Testa L Antimicrob Agents Chemother; 2005 Feb; 49(2):643-9. PubMed ID: 15673746 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography. Droste JA; Verweij-Van Wissen CP; Burger DM Ther Drug Monit; 2003 Jun; 25(3):393-9. PubMed ID: 12766571 [TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma. Wu EY; Wilkinson JM; Naret DG; Daniels VL; Williams LJ; Khalil DA; Shetty BV J Chromatogr B Biomed Sci Appl; 1997 Aug; 695(2):373-80. PubMed ID: 9300874 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography. Justesen US; Pedersen C; Klitgaard NA J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(2):491-500. PubMed ID: 12482492 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir and M8-nelfinavir metabolite. Verbesselt R; Van Wijngaerden E; de Hoon J J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):51-60. PubMed ID: 16997640 [TBL] [Abstract][Full Text] [Related]
9. Bayesian parameter estimates of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1. Payen S; Faye A; Compagnucci A; Giaquinto C; Gibbs D; Gomeni R; Bressolle F; Jacqz-Aigrain E Antimicrob Agents Chemother; 2005 Feb; 49(2):525-35. PubMed ID: 15673728 [TBL] [Abstract][Full Text] [Related]
10. Quantification of tipranavir in human plasma by high-performance liquid chromatography with UV detection. Giraud E; Rey E; Tréluyer JM; Pons G; Jullien V J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):86-90. PubMed ID: 16260190 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography. Hirabayashi Y; Tsuchiya K; Kimura S; Oka S Biomed Chromatogr; 2006 Jan; 20(1):28-36. PubMed ID: 15971289 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography. Poirier JM; Robidou P; Jaillon P Ther Drug Monit; 2002 Apr; 24(2):302-9. PubMed ID: 11897976 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum. Eke AC; McCormack SA; Best BM; Stek AM; Wang J; Kreitchmann R; Shapiro D; Smith E; Mofenson LM; Capparelli EV; Mirochnick M; J Clin Pharmacol; 2019 Mar; 59(3):386-393. PubMed ID: 30358179 [TBL] [Abstract][Full Text] [Related]
14. Subnanogram on-line column-switching liquid chromatographic-tandem mass spectrometric quantification method for nelfinavir and methoxyphenol metabolite M1 in rat plasma. Hua Y; Fan-Havard P; Chan KK J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):1-7. PubMed ID: 15282086 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection. van Heeswijk RP; Hoetelmans RM; Harms R; Meenhorst PL; Mulder JW; Lange JM; Beijnen JH J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):159-68. PubMed ID: 9869376 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography. Sarasa-Nacenta M; López-Púa Y; Mallolas J; Blanco JL; Gatell JM; Carné X J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):325-32. PubMed ID: 11417878 [TBL] [Abstract][Full Text] [Related]
17. Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography. Bouley M; Briere C; Padoin C; Petitjean O; Tod M Ther Drug Monit; 2001 Feb; 23(1):56-60. PubMed ID: 11206045 [TBL] [Abstract][Full Text] [Related]
18. Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma. Keil K; Frerichs VA; DiFrancesco R; Morse G Ther Drug Monit; 2003 Jun; 25(3):340-6. PubMed ID: 12766563 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma. Proust V; Toth K; Hulin A; Taburet AM; Gimenez F; Singlas E J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):453-8. PubMed ID: 10901152 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography. Yamada H; Kotaki H; Nakamura T; Iwamoto A J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):85-9. PubMed ID: 11393736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]